Characterization of a Phage-Encoded Depolymerase Against Klebsiella pneumoniae K30 Capsular Type and Its Therapeutic Application in a Murine Model of Aspiration Pneumonia
Charakterisierung einer phagenkodierten Depolymerase gegen den K30-Kapseltyp von Klebsiella pneumoniae und ihre therapeutische Anwendung in einem murinen Aspirationspneumonie-Modell
Viruses · 30.10.2025 · 17 (11) · 1446
DOI: 10.3390/v17111446 ↗Auf einen Blick
Eine phagenabgeleitete Depolymerase (Dop5) wurde gegen Klebsiella pneumoniae K30 untersucht. Im Mausmodell schützte Dop5 80 % der Tiere vor letaler Infektion.
Fragestellung
Welche Eigenschaften hat die phagenkodierte Depolymerase Dop5 gegen Klebsiella pneumoniae K30, und wirkt sie in einem murinen Aspirationspneumonie-Modell therapeutisch?
Methode
Isolierung und Charakterisierung des lytischen Phagen phiTH1; Identifikation von Dop5, Expression in Escherichia coli und Reinigun
Ergebnisse
Dop5 zeigte in vitro Kapsel-Depolymerase-Aktivität. Im murinen Modell wurden pathologische Schäden in mehreren Organen reduziert, die bakterielle Last gesenkt sowie Entzündungszytokine, Komplement C3 und der Lungenscore vermindert.
Schlussfolgerung der Autor:innen
Die Studie zeigt das Potenzial der Depolymerase Dop5 zur Behandlung von Klebsiella pneumoniae-Infektionen.
Kernaussagen
- Dop5 zielte auf den K30-Kapseltyp von Klebsiella pneumoniae
- In vitro wurde eine Kapsel-Depolymerase-Aktivität gezeigt
- Im Mausmodell schützte Dop5 80 % der Tiere vor letaler Herausforderung
Deutsche Zusammenfassung: KI-gestützt aus dem Original-Abstract erstellt; alle Zahlen wurden automatisch mit dem Original abgeglichen. Maßgeblich ist der Original-Abstract.
Kurz gefasst
Fachartikel in der Zeitschrift Viruses, online erschienen am 30.10.2025. Verfasst von Yuchen Chen und 16 weiteren Autor:innen. Beteiligte Einrichtung: Department of Bacteriology, Capital Institute of Pediatrics, Beijing 100020, China. Hauptthemen laut MEDLINE: Klebsiella pneumoniae, Klebsiella Infections, Bacteriophages, Bacterial Capsules. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 60 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Key Research and Development Program of China, National Natural Science Foundation of China, National Natural Science Foundation of China for Key Programs of China.
Themen: Pneumonieprophylaxe
Abstract (Originalsprache)
Capsular polysaccharides are critical virulence factors of Klebsiella pneumoniae, enabling the bacterium to evade host immune recognition and exacerbate infection. Phage-derived depolymerases, which specifically degrade these capsular polysaccharides, are increasingly recognized as a highly promising strategy for the treatment of bacterial infections. In the present study, we isolated and characterized a lytic Klebsiella pneumoniae phage, named phiTH1, and sequenced its genome. The K30-type capsular polysaccharide was identified as the receptor for phiTH1 infection. A tail fiber protein with a pectate lyase domain, Dop5, was then recognized as a potential K30-type depolymerase. Therefore, the recombinant protein Dop5 was expressed in Escherichia coli and purified, and its in vitro capsular depolymerase activity was demonstrated. Further, by using a murine aspiration pneumonia model induced by K30-type Klebsiella pneumoniae TH1, we found that Dop5 protected 80% of mice from lethal challenge with Klebsiella pneumoniae. After Dop5 treatment, the pathological damage in multiple organs of mice was alleviated, the bacterial load was reduced, and serum levels of inflammatory cytokines and complement C3 decreased, along with a significant reduction in the pathological score of the lungs. Hence, this study revealed the potential of the depolymerase Dop5 for the treatment of Klebsiella pneumoniae infections.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Bacteriology, Capital Institute of Pediatrics, Beijing 100020, China.
- Capital Institute of Pediatrics, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing 100730, China.
ORCID-Profile: Yuehua Ke
Förderung
- National Key Research and Development Program of China
- National Natural Science Foundation of China
- National Natural Science Foundation of China for Key Programs of China
Zitieren
APA
Chen, Y., Fan, Z., Fu, T., Li, Z., Feng, J., Cui, X., Gan, L., Xue, G., Feng, Y., Zhao, H., Cui, J., Yan, C., Xu, Z., Yu, Z., Yang, Y., Ke, Y., & Yuan, J. (2025). Characterization of a Phage-Encoded Depolymerase Against Klebsiella pneumoniae K30 Capsular Type and Its Therapeutic Application in a Murine Model of Aspiration Pneumonia. Viruses, 17(11), 1446. https://doi.org/10.3390/v17111446
Vancouver
Chen Y, Fan Z, Fu T, Li Z, Feng J, Cui X, et al. Characterization of a Phage-Encoded Depolymerase Against Klebsiella pneumoniae K30 Capsular Type and Its Therapeutic Application in a Murine Model of Aspiration Pneumonia. Viruses. 2025;17(11):1446. doi:10.3390/v17111446
BibTeX
@article{Chen2025,
author = {Chen, Yuchen and Fan, Zheng and Fu, Tongtong and Li, Zhoufei and Feng, Junxia and Cui, Xiaohu and Gan, Lin and Xue, Guanhua and Feng, Yanling and Zhao, Hanqing and Cui, Jinghua and Yan, Chao and Xu, Ziying and Yu, Zihui and Yang, Yang and Ke, Yuehua and Yuan, Jing},
title = {Characterization of a Phage-Encoded Depolymerase Against Klebsiella pneumoniae K30 Capsular Type and Its Therapeutic Application in a Murine Model of Aspiration Pneumonia},
journal = {Viruses},
year = {2025},
volume = {17},
number = {11},
pages = {1446},
doi = {10.3390/v17111446}
}
EUVIMED